Clinical trial
Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in…
NCT00003899 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003899 |
|---|---|
| Title | Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors |
| Official title | High-Dose Consolidation With Escalating Doses of Melphalan and Thiotepa for Stage IV Breast Cancer |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, cyclophosphamide, melphalan, paclitaxel, thiotepa, autologous bone marrow transplantation, peripheral blood stem cell transplantation |
| Start date | Jan 1, 1999 |
| Completion | Nov 1, 2001 |
| First posted | Apr 23, 2004 |
| Last update posted | Oct 4, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: